how frequently patients are disqualified from transplantation due to inadequate social support, and whether social support criteria disproportionately impact vulnerable populations. Vulnerable groups may face greater difficulty demonstrating social support due to challenges bringing caregivers to healthcare appointments and inability to self-finance home-based assistance. 4, [9] [10] [11] [12] [13] [14] [15] [16] Lack of clear guidelines for defining and evaluating social support may also contribute to significant variation across transplant centers, resulting in unequal access to the waitlist. Moreover, subjective criteria such as social support are especially susceptible to implicit bias, exacerbating concerns about inconsistent use and disparities. 17, 18 As such, countries including Canada and the European Union have recently removed social support considerations from the list of transplant eligibility criteria. 19, 20 Yet in the United States, inadequate social support remains a contraindication to transplantation.
It remains unclear how much providers rely upon social support in listing determinations, how much variation exists in use of social support, and whether providers perceive social support criteria as fair. Providers' perceptions that social support is used inconsistently in listing decisions (procedural justice concerns) or that some groups of patients face disproportionate difficulty meeting these criteria (distributive justice concerns) may increase variation in its use among providers. 21, 22 Clinical factors can also affect the perceived legitimacy of the criteria and providers' reliance on social support. 21, 23 Factors shown to affect perceived legitimacy include tradition (experience using social support at their center), expertise (confidence in using the criteria to determine eligibility), and legality (clarity of the federal mandate
Centers for Medicare and Medicaid Services [CMS] guidelines for social support evaluation). 24, 25 Taken together, differences in clinicians' attitudes towards the criteria may partly explain variation in use of social support criteria and subsequent inequalities in access to the waitlist.
Social support criteria remain controversial and may undermine consistency, transparency, and equity in the evaluation process. Consequently, providers may differ in their attitudes towards social support criteria. Yet, no studies have estimated its impact or providers' attitudes towards social support criteria. The objective of this national study of transplant providers was to examine how frequently social support criteria affect waitlisting decisions and whether certain patient groups are disproportionately affected by these criteria. We also examine providers' perceptions of fairness and legitimacy of social support criteria and desire for improved clarity. Understanding the impact of social support is critical for ensuring that patients are held to clear, uniform standards, and for upholding transparency and equity in access to transplantation.
| ME THODS

| Survey design and administration
A 35-item survey instrument was developed following a meta-analysis and literature review, 7 in-depth interviews about experiences using social support criteria and survey domains with transplant surgeons (kidney, liver, and heart), nephrologists, and transplant social workers (n = 6), and in consultation with a multidisciplinary group of transplant experts (surgeon, psychologist, social scientists, ethicists, and social workers). The instrument was revised following input from the These measures are consistent with those widely used in prior studies. [25] [26] [27] Because socioeconomic status has consistently been associated with disparities in access to transplant, respondents were asked whether patients of lower socioeconomic status were as able as those of higher socioeconomic status to demonstrate adequate social support. 1, 2, 28 Responses ranged from strongly disagree to strongly agree on a 5-point Likert scale. To ensure validity and interpretability, the survey was pretested using cognitive interviews asking respondents to "think aloud" about the questions and response options (n = 6), resulting in revised questions, response options, and inclusion of openended questions. 29 The survey was then pilot tested to confirm the feasibility and estimate time to completion. 29 The study was approved by the Tufts University Institutional Review Board. 
| Statistical analyses
We conducted bivariate analyses using Pearson χ 2 tests to describe respondents' beliefs and preferences related to social support criteria, by organ type (eg, abdominal vs thoracic) and clinical role (eg, psychosocial providers versus medical/surgical providers).
Logistic regression models examined variation in providers' attitudes towards social support criteria, based on ethical and sociological theories of perceived legitimacy. 22, 23, 25 
| RE SULTS
Overall, 604 clinicians from 202 transplant centers completed the survey (41% response rate), of whom 551 had complete information and were included in the analysis. This response rate is considered high for a sample of clinicians. 26, 27 A nonresponse analysis comparing late respondents (those responding after a third reminder) revealed no significant differences. Respondents' characteristics are shown in Table 1 . Nearly half (47%) were psychosocial providers; 53% were surgical/medical providers (surgeons, nephrologists, hepatologists, etc.). Most were involved in kidney transplantation (72.6%), followed by liver (53%), pancreas (39.9%), heart (13.4%), and lung (7.8%); 87% were involved in multiple organ programs.
Respondents had an average of 16.6 (SD = 11.3) years in practice (Table 1 ). There were 82 instances in which respondents reported being from the same medical center, though in 64 of these instances, fewer than 5 represented the same medical center. Only 5 centers had multiple participants from the same medical center within same organ transplant program, ranging from 5 to 9 participants.
| Impact of the social support criteria and lack of transparency
Transplant providers estimated that, on average, 9.6% (standard Patients were not universally informed that they were ruled out due to inadequate support, even when this occurred. Although most (79.3%) providers perceived that patients were informed when insufficient social support contributes to a negative listing decision, one fifth (21.6%) did not. Psychosocial providers were significantly more likely to report that patients were informed when social support contributed to negative listing decisions than medical/surgical providers (85.3% vs 73.9%, P = .002).
| Disparities in meeting social support criteria
Two thirds of clinicians (67.3%) agreed that patients with higher socioeconomic status were more often able to demonstrate adequate social support than those with lower socioeconomic status. Half (50.3%) thought that demonstrating social support is more challenging for some patients based on socioeconomic status, age, or sex, and only one third (33.5%) disagreed with that statement. Most respondents (85.5%) thought that patients' lifestyle choices and health behaviors, such as prior history of substance use, determine their ability to demonstrate adequate social support. Importantly, only half of respondents (52.5%) believed that social support was modifiable. Though most viewed it as fair (75.6%), one fifth of respondents (19.3%) did not believe that the process of evaluating patients' social support at their center was impartial or neutral. Psychosocial providers were significantly less likely than medical/surgical providers to perceive the evaluation process as impartial (79.8% vs 81.5%, P = .025).
| Low provider confidence and desire for improved guidelines
Widespread use of social support criteria did not correspond with high levels of confidence in it. Nearly half of respondents (42.4%) were only somewhat or not at all confident in using social support to determine transplant suitability, with 57.6% being confident ( Figure 1 ). Medical/surgical providers (compared to psychosocial providers) and providers in abdominal transplant programs (versus thoracic) were less confident in using social support (32.8% vs 51.3%; P < .001; and 28.2% vs 45.2%; P = .004, respectively). Only 17.3% of providers considered CMS' guidelines for evaluating and using social support in transplant decisions to be clear. Moreover, while 71% agreed that their center used clear, detailed, and consistent guidelines for evaluating social support, 29% disagreed or were unsure.
Overall, 70% supported the development of a more uniform approach to social support evaluation.
| Fairness and perceived legitimacy of social support criteria
One quarter of providers (24.3%) thought using social support to determine transplant eligibility was unfair or were unsure about its fairness (Figure 1 ). Medical/surgical providers were more than Using SS to determine transplant eligibility is fair.
Patients with higher SES are often more able to demonstrate adequate SS than those with lower SES.
Demonstrating SS is more challenging for some patients, based on personal characteristics (SES, age, or gender).
Inadequate pre-transplant SS is strongly predictive of non-adherence post-transplantation.
Our center uses clear, detailed, and consistent guidelines for evaluating SS.
How confident are you in using social support to make determinations about transplant eligibility?* Generally, patients with inadequate SS should be evaluated less favorably for transplantation than similar patients with greater SS.
The
Percentage of providers agreeing
twice as likely as psychosocial providers to perceive use of social support as unfair (P = .006). In multivariate logistic regression models, distributive factors (related to disproportionate impact on vulnerable populations) and procedural concerns (related to the uniformity, impartiality, and transparency) were significantly associated with perceived fairness of social support criteria (Table 2) .
Respondents who believed that demonstrating social support is more challenging based on age, sex, or socioeconomic status were significantly less likely to perceive social support criteria as fair (odds ratio 0.32, P = .002) (distributive factor). Those who believed that social support was modifiable were 1.89 more likely to view social support as fair (P = .055). Respondents who perceived their center's policies for evaluating social support were clear and consistent were 2.29 (P < .05) times more likely to perceive the criteria as fair. Moreover, respondents at centers that always informed patients when social support contributes to negative listing decisions had 2.34 greater odds of perceiving the criteria as fair (P = .017).
Taken together, concerns about disparities, patients' control over their level of social support, and opaque clinical practices explained 20% of the variation in perceived fairness of the criteria.
Respondents were divided over whether social support should be used for determining transplant eligibility (legitimacy). While 86.3% of respondents agreed that patients with inadequate support were less likely to be listed, only 67.6% believed that this should be the case.
While 71.4% perceived social support was important for preventing organ waste (utility), respondents were less sure about the evidence for this. Only 61.4% believed that lack of social support was strongly predictive of medication nonadherence posttransplant (Figure 1 ).
Multivariate models identified factors associated with perceived legitimacy of social support criteria ( Table 3 ). Beliefs that social support criteria were important for preventing organ waste (utility) and were fair were associated with 10.54 (P < .0001) and 9.24 (P < .0001) greater odds of perceiving the criteria as legitimate (ie, that social support should influence listing decisions). These factors remained significant when controlling for the percent of patients excluded during the past year at the respondent's center (experience), respondents' confidence in using the criteria (expertise), and perceived clarity of CMS guidelines regarding social support (legality). UNOS region and clinical role were also included in the model. Psychosocial 
TA B L E 2 Modifiable clinical factors (procedural) and societal factors (distributive) associated with providers' perception that using social support (SS) in listing decisions is fair
Belief that using SS to determine eligibility for transplant is fair (odds ratios) Logistic regression models predict the probability of agreeing or strongly agreeing that it is fair to use social support to determine patient eligibility for transplant. Indicators for respondent United Network for Organ Sharing Region were included in the model but did not achieve significance. Full questions and complete results, including 95% confidence intervals, are available upon request. SES, socioeconomic status. *P < .10, **P < .05, ***P < .01.
| D ISCUSS I ON
Despite federal guidelines mandating equitable access to scarce organs, 30 significant disparities remain in access to the waitlist.
11, 28
Our findings demonstrate that social support represents an influential and understudied source of disparities in access to transplantation. This national study of transplant providers found that an estimated 10%-22% of transplant candidates were excluded due to inadequate support last year. Furthermore, 67% of providers believed use of social support disproportionately impacted patients of lower socioeconomic status and only 52% believed that social support was modifiable. Significantly more providers used the social support criteria in decision-making than believed they ought to be used (86% vs 68%). A sizable minority (25%) believed that using social support criteria in listing determinations was unfair, or they were unsure. There is substantial discomfort with the social support criteria: only 42% of respondents were only somewhat or not at all confident in using social support to determine transplant suitability.
These data show, for the first time, that providers perceive that a significant proportion of patients are excluded from transplant waitlists because of social support, even though many providers lack confidence in current social support criteria and believe their use is unfair and disproportionately affects poorer patients.
Recent scrutiny of similar eligibility criteria, such as cognitive impairment and sobriety periods, has resulted in lawsuits and state laws prohibiting use of cognitive impairment as an eligibility criterion. 31 The social support criteria are susceptible to similar concerns due to their tenuous evidence base and potential for increasing disparities among socially vulnerable patients. 32 Our findings clarify a need and an opportunity for the transplant community to revise Logistic regression models predict the probability of agreeing or strongly agreeing that patients with less SS ought to be evaluated less favorably for transplant. Indicators for respondent United Network for Organ Sharing Region were included in the model but did not achieve significance. Full questions and complete results, including 95% confidence intervals, are available upon request. CMS, Centers for Medicare and Medicaid Services. **P < .05, ***P < .01.
otherwise, bearing on their ability to receive lifesaving treatment.
Upholding the ethical principles of autonomy, beneficence, and justice requires that transplant teams inform patients when social support contributes to a negative listing decision. 45 When properly informed, patients and care teams can best determine future steps, including bolstering or better demonstrating existing social support. 46 Future studies should also examine whether processes exist for patients to appeal judgments about their social support or obtain a second opinion in cases of disagreement.
Understanding whether transplant providers perceive the social support criteria as legitimate and fair is critical to understanding variation in clinical practice and ensuring equitable treatment of patients. Although most providers thought the social support criteria were fair, a sizable minority (25%) believed they were unfair. Although the distributive concerns are difficult to address, procedural fairness can be remedied through process improvements. 22 Beyond transparency when patients are ruled out due 
47,48
As with all surveys, our study was subject to nonsampling error, including nonresponse bias. However, results of a nonresponse analysis reveal that nonresponders did not differ on demographic or center characteristics, and the attitudes of late responders did not differ significantly from others. Moreover, when calculating the response rate based on the membership list, we attempted to remove members practicing exclusively internationally and in pe- 
| CON CLUS IONS
Providers estimate that inadequate social support excludes up to 20% of transplant candidates needing an organ transplant. A majority of transplant providers believed that social support criteria disproportionately impacted patients of low socioeconomic status, and nearly half of providers lacked confidence in current social support criteria. These data suggest a need to better define and determine how social support should be used in listing decisions to reduce disparities in access to transplantation.
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